Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies

AL Mueller, Z Payandeh, N Mohammadkhani… - Cells, 2021 - mdpi.com
Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and
progressive autoimmune disease affecting many people worldwide. While patients show …

Transferosomes as a transdermal drug delivery system: Dermal kinetics and recent developments

N Matharoo, H Mohd… - Wiley Interdisciplinary …, 2024 - Wiley Online Library
The development of innovative approaches to deliver medications has been growing now
for the last few decades and generates a growing interest in the dermatopharmaceutical …

[HTML][HTML] Topical nanocarriers for management of Rheumatoid Arthritis: A review

C Anita, M Munira, Q Mural, L Shaily - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Rheumatoid arthritis (RA) is a systemic autoimmune disease manifested by chronic joint
inflammation leading to severe disability and premature mortality. With a global prevalence …

Transfersomes: a revolutionary nanosystem for efficient transdermal drug delivery

MW Akram, H Jamshaid, FU Rehman, M Zaeem… - AAPS …, 2022 - Springer
Transdermal delivery system has gained significance in drug delivery owing to its
advantages over the conventional delivery systems. However, the barriers of stratum …

Effect of curcumin on rheumatoid arthritis: a systematic review and meta-analysis

H Kou, L Huang, M Jin, Q He, R Zhang… - Frontiers in …, 2023 - frontiersin.org
Objective The aim of this study is to evaluate the effectiveness and safety of curcumin in
rheumatoid arthritis patients. Methods A computerized search from PubMed, Embase …

Advanced multifunctional nano-lipid carrier loaded gel for targeted delivery of 5-flurouracil and cannabidiol against non-melanoma skin cancer

N Hasan, M Imran, A Sheikh, N Tiwari, A Jaimini… - Environmental …, 2023 - Elsevier
Non-melanoma skin cancer is one of the most common malignancies reported around the
globe. Current treatment therapies fail to meet the desired therapeutic efficacy due to high …

Gout therapeutics and drug delivery

X Peng, X Li, B Xie, Y Lai, A Sosnik, H Boucetta… - Journal of Controlled …, 2023 - Elsevier
Gout is a common inflammatory arthritis caused by persistently elevated uric acid levels.
With the improvement of people's living standards, the consumption of processed food and …

A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c …

H Jamshaid, FU Din, M Malik, M Mukhtiar, HG Choi… - Scientific Reports, 2022 - nature.com
Herein, Imiquimod (IMQ) was incorporated in nanotransethosomes (nTES) to develop the
IMQ-nTES nano-drug delivery system. IMQ-nTES was optimized using 23 factorial design …

Enhancing therapeutic efficacy of curcumin: Advances in delivery systems and clinical applications

H Omidian, RL Wilson, SD Chowdhury - Gels, 2023 - mdpi.com
Curcumin, a potent active compound found in turmeric and Curcuma xanthorrhiza oil,
possesses a wide range of therapeutic properties, including antibacterial, anti-inflammatory …

[HTML][HTML] Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis

Y Xu, M Zhao, J Cao, T Fang, J Zhang, Y Zhen… - … Pharmaceutica Sinica B, 2023 - Elsevier
Rheumatoid arthritis is a chronic, systemic autoimmune disease predominantly based on
joint lesions with an extremely high disability and deformity rate. Several drugs have been …